'Xeloda' presentation slideshows

Welcome

Welcome. Chris Twelves University of Leeds and Bradford NHS Trust UK. Evolution of treatment: new opportunities for Xeloda in breast cancer (BC). Neoadjuvant BC proof of concept for model biologics and targeted therapies Adjuvant BC replace 5-FU in standard anthracycline-based regimens

1.14k views • 95 slides

Xeloda for the adjuvant treatment of stage III colon cancer

523 views • 38 slides

Management choices in breast cancer: maximizing survival with Xeloda

Management choices in breast cancer: maximizing survival with Xeloda. Laura Biganzoli Sandro Pitigliani Medical Oncology Unit Hospital of Prato Prato, Italy Andrew Wardley Christie Hospital and South Manchester University Hospital Manchester, UK. Clinical case history 1.

519 views • 33 slides

A clinical challenge: integrating all agents

A clinical challenge: integrating all agents. Edith A Perez, MD Mayo Clinic Jacksonville, Florida, USA Introduction by Christoph Zielinski University Hospital Vienna, Vienna, Austria. Case history. 49-year-old woman: 1.4cm lesion in the left breast Lumpectomy and axillary lymphadenectomy

414 views • 29 slides

Case study 1

420 views • 21 slides

436 views • 21 slides

Xeloda X -panding options in the adjuvant treatment of breast cancer

Xeloda X -panding options in the adjuvant treatment of breast cancer. Christopher J Poole Macmillan Senior Lecturer Medical Oncology University Hospital Birmingham, UK. Evaluation of Xeloda in adjuvant chemotherapy for women with early BC (n>20 000).

421 views • 20 slides

Lighting the way ahead: novel approaches to breast cancer treatment with Xeloda

Lighting the way ahead: novel approaches to breast cancer treatment with Xeloda. Miguel Martin Hospital Universitario San Carlos Madrid, Spain. Novel treatment approaches with Xeloda. Metastatic breast cancer Sequential monotherapy All-oral regimens Novel schedules of administration

390 views • 20 slides

The X-ACT trial: a breakthrough for the adjuvant treatment of colon cancer

438 views • 19 slides

Xeloda: a first choice in metastatic breast cancer

526 views • 18 slides

Future development in breast cancer

Future development in breast cancer. Kathy Miller Indiana University School of Medicine USA. Rational combinations with novel agents in MBC. Proven activity Avastin, Herceptin, Xeloda monotherapy Avastin plus chemotherapy (paclitaxel) Herceptin plus chemotherapy (taxanes)

263 views • 16 slides

X-tending the horizons of Xeloda into early breast cancer (BC)

X-tending the horizons of Xeloda into early breast cancer (BC). Wolfgang Janni Ludwig Maximilians University of Munich Munich, Germany. Rationale for integrating Xeloda into the treatment of early BC. High single-agent efficacy in metastatic BC

254 views • 16 slides

The future for elderly patients: adjuvant Xeloda

310 views • 14 slides

Management choices in breast cancer: maximizing survival with Xeloda

241 views • 6 slides